Lobbying Activity Report

1326-44214

Organization: Eli Lilly Canada Inc.
Associated registration: 11281-1326-28
Lobbying Activity date: 2025-06-11
Arranged a meeting: No
Posted date: 2025-07-15

In-house lobbyists who participated in the lobbying activity: Dean Stewart
Christopher Praught
Jill Daley
Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Chris Ingram, Director
Therapeutic Assessment and Access Branch, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Health - Development, establishment, amendment or termination of any program, policy or decision, with respect to:
Policy discussions related to Patented Medicine Prices Review Board (PMPRB) and pharmaceutical pricing, pan-Canadian Pharmaceutical Alliance (pCPA) initiatives, public drug plan reimbursement and design and health system design
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Mathilde Merlet
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Canadian Institute for Advanced Research (CIFAR)
Date Modified: